123 related articles for article (PubMed ID: 2898137)
1. Association of psychosis and movement disorders in the elderly.
Lohr JB; Bracha HS
Psychiatr Clin North Am; 1988 Mar; 11(1):61-81. PubMed ID: 2898137
[TBL] [Abstract][Full Text] [Related]
2. [Abnormal movements induced by psychotropic drugs].
Rondot P; Bathien N
Encephale; 1979; 5(1):41-8. PubMed ID: 477589
[TBL] [Abstract][Full Text] [Related]
3. Psychosis in elderly patients: classification and pharmacotherapy.
Mintzer J; Targum SD
J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):199-206. PubMed ID: 14653427
[TBL] [Abstract][Full Text] [Related]
4. [Senile dyskinesias and tardive dyskinesias].
Brion S; Plas J; Chevalier JF; Dussaux P
Encephale; 1988 Sep; 14 Spec No():215-9. PubMed ID: 2905649
[TBL] [Abstract][Full Text] [Related]
5. The emerging role of clozapine in the treatment of movement disorders.
Factor SA; Friedman JH
Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological management of psychosis in elderly patients with parkinsonism.
Hasnain M; Vieweg WV; Baron MS; Beatty-Brooks M; Fernandez A; Pandurangi AK
Am J Med; 2009 Jul; 122(7):614-22. PubMed ID: 19559160
[TBL] [Abstract][Full Text] [Related]
7. [Electrophysiological and pharmacological analysis of L-dopa-induced dyskinesia and tardive dyskinesia (author's transl)].
Bathien N; Rondot P; Koutlidis RM
J Physiol (Paris); 1981 Apr; 77(1):131-41. PubMed ID: 6112268
[TBL] [Abstract][Full Text] [Related]
8. Tardive dyskinesia: pathophysiology and animal models.
Casey DE
J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
[TBL] [Abstract][Full Text] [Related]
9. [Neuroleptic-induced movement disorders: historical perspectives].
Wolf MA; Yassa R; Llorca PM
Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
[TBL] [Abstract][Full Text] [Related]
10. Historical perspective on movement disorders.
Friedman JH
J Clin Psychiatry; 2004; 65 Suppl 9():3-8. PubMed ID: 15189105
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of antipsychotic drug-induced movement disorders.
Casey DE
J Clin Psychiatry; 2004; 65 Suppl 9():25-8. PubMed ID: 15189109
[TBL] [Abstract][Full Text] [Related]
12. Drug-induced movement disorders in children.
Gilbert DL
Ann N Y Acad Sci; 2008 Oct; 1142():72-84. PubMed ID: 18990122
[TBL] [Abstract][Full Text] [Related]
13. Clozapine therapy for Parkinson's disease and other movement disorders.
Pfeiffer C; Wagner ML
Am J Hosp Pharm; 1994 Dec; 51(24):3047-53. PubMed ID: 7856623
[TBL] [Abstract][Full Text] [Related]
14. Domperidone-induced tardive dyskinesia and withdrawal psychosis in an elderly woman with dementia.
Roy-Desruisseaux J; Landry J; Bocti C; Tessier D; Hottin P; Trudel JF
Ann Pharmacother; 2011 Sep; 45(9):e51. PubMed ID: 21852591
[TBL] [Abstract][Full Text] [Related]
15. Neurological motor disorders experienced as religious phenomena: role of abnormal movement monitoring.
Lauerma H; Tuliharju M
Brain Cogn; 1998 Feb; 36(1):52-6. PubMed ID: 9500883
[TBL] [Abstract][Full Text] [Related]
16. Typical and atypical neuroleptics.
Gershanik OS; Gómez Arévalo GJ
Handb Clin Neurol; 2011; 100():579-99. PubMed ID: 21496609
[TBL] [Abstract][Full Text] [Related]
17. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
Dean CE; Kuskowski MA; Caligiuri MP
J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic agents: a review.
Dilsaver SC
Am Fam Physician; 1993 Jan; 47(1):199-204. PubMed ID: 8418582
[TBL] [Abstract][Full Text] [Related]
19. New nomenclature for drug-induced movement disorders including tardive dyskinesia.
Chouinard G
J Clin Psychiatry; 2004; 65 Suppl 9():9-15. PubMed ID: 15189106
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
Casey DE
Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
